Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.47 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.47 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.43 |
| ▸ | BLM | P54132 | 3/20 | 0.43 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL344632 | 1.00 | — | — | |
| Acetic Acid SCHEMBL5073310 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL20617 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL6251436 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL6251803 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL1665368 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL1058300 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL11012463 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL8527135 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL220259 | 1.00 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122038491-A | Application of phoxim in improving yield of organic acid produced by fermentation of filamentous fungi | 南京师范大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260124342-A1 | NANOSTRUCTURED LOW-IMMUNOGENIC BIOLOGICAL ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD THEREFOR | HUMATRIX MEDICAL TECH SUZHOU CO LTD (CN) | 2026-05-07 | — | — | US | claimed |
| US-12595388-B2 | Aqueous dispersion of cerium (III) carbonate particles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-07 | — | — | US | claimed |
| EP-4678020-A1 | AN AEROSOL GENERATING MATERIAL | Nicoventures Trading Limited (GB) | 2026-01-14 | — | — | EP | claimed |
| EP-4678019-A1 | AN AEROSOL GENERATING MATERIAL | Nicoventures Trading Limited (GB) | 2026-01-14 | — | — | EP | claimed |
| EP-4678014-A1 | AN AEROSOL GENERATING MATERIAL | Nicoventures Trading Limited (GB) | 2026-01-14 | — | — | EP | claimed |
| EP-4678018-A1 | AN AEROSOL GENERATING MATERIAL | Nicoventures Trading Limited (GB) | 2026-01-14 | — | — | EP | claimed |
| US-20250249427-A1 | PREPARATION METHOD OF GRAPHENE-BASED COMPOSITE AEROGEL MATERIAL FOR ADSORBING HEAVY METAL IONS | KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-08-07 | — | — | US | claimed |
| EP-4578470-A1 | NANOSTRUCTURED LOW-IMMUNOGENIC BIOLOGICAL ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD THEREFOR | Humatrix Medical Technology (Suzhou) Co., Ltd. (CN) | 2025-07-02 | — | — | EP | claimed |
| CN-120152596-A | Lead-tin perovskite precursor material, lead-tin perovskite solar cell and application | 嘉庚创新实验室 | 2025-06-13 | — | — | CN | claimed |
| EP-0532809-B1 | Light-polarizing material based on ethylenediamine polyacetic acid derivatives | RESEARCH FRONTIERS INC (US) | 1996-02-28 | — | — | EP | claimed |
| US-5491261-A | INTERMEDIATES FOR POLYURETHANES, OIL AND WATER REPELLENT MATERIALS; PAPER SIZING | CIBA-GEIGY CORPORATION (US) | 1996-02-13 | — | — | US | claimed |
| EP-0690039-A2 | Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof | CIBA-GEIGY AG (CH) | 1996-01-03 | — | — | EP | claimed |
| US-5449822-A | Preparation of ethylenediaminetriacetic acid | HAMPSHIRE CHEMICAL CORP. (US) | 1995-09-12 | — | — | US | claimed |
| EP-0560910-A1 | MOLECULAR SIEVE-ENCLOSED PARAMAGNETIC ION FOR DIAGNOSIS. | UNIV TEXAS (US) | 1993-09-22 | — | — | EP | claimed |
| EP-0532809-A1 | Light-polarizing material based on ethylenediamine polyacetic acid derivatives | RESEARCH FRONTIERS INCORPORATED (US) | 1993-03-24 | — | — | EP | claimed |
| WO-1992010213-A1 | MOLECULAR SIEVE-ENCLOSED PARAMAGNETIC ION FOR DIAGNOSIS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-06-25 | — | — | WO | claimed |
| US-5093041-A | Light-polarizing material based on ethylenediamine polyacetic acid derivatives | RESEARCH FRONTIERS INCORPORATED (US) | 1992-03-03 | — | — | US | claimed |
| US-4913812-A | GLYCIDYL VINYL(ETHER OR ESTER)COPOLYMER BONDED TO LIGAND | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1990-04-03 | — | — | US | claimed |
| US-4067962-A | ANTISTAINING | THE PROCTER & GAMBLE COMPANY (US) | 1978-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124342-A1 | NANOSTRUCTURED LOW-IMMUNOGENIC BIOLOGICAL ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD THEREFOR | ALPP, ALPL, VEGFA | FFAR3 4773/4885LCK 1957/4885FYN 2022/4885 |
| US-12595388-B2 | Aqueous dispersion of cerium (III) carbonate particles | RNMT, CAPZA2, LBR | FFAR3 2291/4885LCK 3591/4885FYN 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.